75000 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 75010 - Statement - Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 75020 - Statement - Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 75030 - Statement - Consolidated Statements of Operations and Comprehensive Loss link:presentationLink link:calculationLink link:definitionLink 75040 - Statement - Consolidated Statements of Series A Preferred Shares and Shareholders' Equity link:presentationLink link:calculationLink link:definitionLink 75050 - Statement - Consolidated Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 995455 - Disclosure - Cybersecurity Risk Management, Strategy, and Governance link:presentationLink link:calculationLink link:definitionLink 995465 - Disclosure - The Company link:presentationLink link:calculationLink link:definitionLink 995475 - Disclosure - Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 995485 - Disclosure - Property and Equipment, Net link:presentationLink link:calculationLink link:definitionLink 995495 - Disclosure - Accrued Expenses and Other Current Liabilities link:presentationLink link:calculationLink link:definitionLink 995505 - Disclosure - Collaboration Agreements link:presentationLink link:calculationLink link:definitionLink 995515 - Disclosure - Share Capital link:presentationLink link:calculationLink link:definitionLink 995525 - Disclosure - Share-Based Compensation link:presentationLink link:calculationLink link:definitionLink 995535 - Disclosure - Leases link:presentationLink link:calculationLink link:definitionLink 995545 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 995555 - Disclosure - Net Loss Per Ordinary Share link:presentationLink link:calculationLink link:definitionLink 995565 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 995575 - Disclosure - Employee Benefit Plans link:presentationLink link:calculationLink link:definitionLink 995585 - Disclosure - Related Parties link:presentationLink link:calculationLink link:definitionLink 995595 - Disclosure - Segment Information link:presentationLink link:calculationLink link:definitionLink 995605 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 995615 - Disclosure - Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 995625 - Disclosure - Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 995635 - Disclosure - Property and Equipment, Net (Tables) link:presentationLink link:calculationLink link:definitionLink 995645 - Disclosure - Accrued Expenses and Other Current Liabilities (Tables) link:presentationLink link:calculationLink link:definitionLink 995655 - Disclosure - Collaboration Agreements (Tables) link:presentationLink link:calculationLink link:definitionLink 995665 - Disclosure - Share-Based Compensation (Tables) link:presentationLink link:calculationLink link:definitionLink 995675 - Disclosure - Leases (Tables) link:presentationLink link:calculationLink link:definitionLink 995685 - Disclosure - Net Loss Per Ordinary Share (Tables) link:presentationLink link:calculationLink link:definitionLink 995695 - Disclosure - Income Taxes (Tables) link:presentationLink link:calculationLink link:definitionLink 995705 - Disclosure - Segment Information (Tables) link:presentationLink link:calculationLink link:definitionLink 995715 - Disclosure - The Company - Additional Information (Detail) link:presentationLink link:calculationLink link:definitionLink 995725 - Disclosure - Significant Accounting Policies - Additional Information (Detail) link:presentationLink link:calculationLink link:definitionLink 995735 - Disclosure - Significant Accounting Policies - Schedule of Estimated Useful Lives of Assets (Detail) link:presentationLink link:calculationLink link:definitionLink 995745 - Disclosure - Significant Accounting Policies - Additional Information (Detail 1) link:presentationLink link:calculationLink link:definitionLink 995755 - Disclosure - Property and Equipment, Net - Schedule of Property and Equipment, Net (Detail) link:presentationLink link:calculationLink link:definitionLink 995765 - Disclosure - Property and Equipment, Net - Additional Information (Detail) link:presentationLink link:calculationLink link:definitionLink 995775 - Disclosure - Accrued Expenses and Other Current Liabilities - Summary of Accrued Expenses and Other Current Liabilities (Detail) link:presentationLink link:calculationLink link:definitionLink 995785 - Disclosure - Collaboration Agreements - Additional Information (Detail) link:presentationLink link:calculationLink link:definitionLink 995795 - Disclosure - Collaboration Agreements - Summary Of Allocation of The Total Transaction Price (Details) link:presentationLink link:calculationLink link:definitionLink 995805 - Disclosure - Share Capital - Additional Information (Detail) link:presentationLink link:calculationLink link:definitionLink 995815 - Disclosure - Share-Based Compensation - Additional Information (Detail) link:presentationLink link:calculationLink link:definitionLink 995825 - Disclosure - Share-Based Compensation - Summary of Share Option Activity (Detail) link:presentationLink link:calculationLink link:definitionLink 995835 - Disclosure - Share-Based Compensation - Summary of Fair Value of Share Options Granted to Employees (Detail) link:presentationLink link:calculationLink link:definitionLink 995845 - Disclosure - Share-Based Compensation - Summary of RSU Activity (Detail) link:presentationLink link:calculationLink link:definitionLink 995855 - Disclosure - Share-Based Compensation - Summary of Share-based Compensation Expense Classified in Consolidated Statements of Operations and Comprehensive Loss (Detail) link:presentationLink link:calculationLink link:definitionLink 995865 - Disclosure - Leases - Additional Information (Detail) link:presentationLink link:calculationLink link:definitionLink 995875 - Disclosure - Leases - Summary of Lease Costs Recognized and Other Information Pertaining to Operating Leases (Detail) link:presentationLink link:calculationLink link:definitionLink 995885 - Disclosure - Leases - Schedule of Future Minimum Rental Payments for Operating Leases Under Topic 842 (Detail) link:presentationLink link:calculationLink link:definitionLink 995895 - Disclosure - Leases - Schedule of Future Minimum Rental Payments for Operating Leases Under Topic 842 (Detail) 2 link:presentationLink link:calculationLink link:definitionLink 995905 - Disclosure - Net Loss Per Ordinary Share - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995915 - Disclosure - Net Loss Per Ordinary Share - Summary of Basic and Diluted Net Loss Per Ordinary Share Outstanding (Detail) link:presentationLink link:calculationLink link:definitionLink 995925 - Disclosure - Net Loss Per Ordinary Share - Anti-Dilutive Shares Excluded from Calculation of Diluted Net Loss Per Ordinary Share (Detail) link:presentationLink link:calculationLink link:definitionLink 995935 - Disclosure - Income Taxes - Components of Loss before Income Taxes (Detail) link:presentationLink link:calculationLink link:definitionLink 995945 - Disclosure - Income Taxes - Additional Information (Detail) link:presentationLink link:calculationLink link:definitionLink 995955 - Disclosure - Income Taxes - Deferred Components of Benefit (Provision), Net for Income Taxes (Detail) link:presentationLink link:calculationLink link:definitionLink 995965 - Disclosure - Income Taxes - Reconciliation of Statutory Income Tax Rate (Detail) link:presentationLink link:calculationLink link:definitionLink 995975 - Disclosure - Income Taxes - Components of Deferred Tax Assets and Liabilities (Detail) link:presentationLink link:calculationLink link:definitionLink 995985 - Disclosure - Income Taxes - Summary of Valuation Allowance (Detail) link:presentationLink link:calculationLink link:definitionLink 995995 - Disclosure - Income Taxes - Summary of Activity in Gross Unrecognized Tax Benefits Excluding Interest and Penalties (Detail) link:presentationLink link:calculationLink link:definitionLink 996005 - Disclosure - Employee Benefit Plans - Additional Information (Detail) link:presentationLink link:calculationLink link:definitionLink 996015 - Disclosure - Related Parties - Additional Information (Detail) link:presentationLink link:calculationLink link:definitionLink 996025 - Disclosure - Segment Information - Additional Information (Detail) link:presentationLink link:calculationLink link:definitionLink 996035 - Disclosure - Segment Information - Schedule of Reconciliation to Consolidated Operating Expenses (Details) link:presentationLink link:calculationLink link:definitionLink 999009 - Disclosure - Anchoring link:presentationLink link:calculationLink link:definitionLink Contract research services Research and Development Arrangement, Contract to Perform for Others, Compensation Earned Vested, Average Grant Date Fair Value Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Proceeds from Sale of Property, Plant, and Equipment, Total Proceeds from Sale of Property, Plant, and Equipment Proceeds from the sale of property and equipment Related Party Tax Expense, Due to Affiliates, Current Expenses incurred Consulting Agreement [Member] Consulting Agreement [Member] Consulting Agreement [Member] Software [Member] Software Development [Member] Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Increase (Decrease) in Accounts Payable, Total Accounts payable Increase (Decrease) in Accounts Payable Plan Name Plan Name [Axis] Equity [Abstract] Entity Current Reporting Status Entity Current Reporting Status Japan [Member] JAPAN Operating expenses: Operating Expenses [Abstract] Fair Value, Inputs, Level 2 [Member] Level 2 Net deferred tax assets Deferred Tax Assets, Net of Valuation Allowance Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Common stock, authorized Common Stock, Shares Authorized Series A preferred stock, par value Temporary Equity, Par or Stated Value Per Share Investment, Policy [Policy Text Block] Short-Term Investments Product and Service Product and Service [Axis] Document Fiscal Period Focus Document Fiscal Period Focus Rule 10 B 51 Arr Modified Flag Rule 10b5-1 arrangement modified. Rule 10b5-1 Arrangement Modified Entity Shell Company Entity Shell Company Temporary equity, Ending balance, shares Temporary Equity, Shares Outstanding Series A preferred stock, shares outstanding Temporary equity, Beginning balance, shares Series A preferred shares outstanding Christopher Francis [Member] Christopher Francis. Short-Term Investments [Member] Segment Data Segment Reporting, Policy [Policy Text Block] Cash and Cash Equivalents, at Carrying Value, Ending Balance Cash and Cash Equivalents, at Carrying Value, Beginning Balance Cash and Cash Equivalents, at Carrying Value, Total Cash and cash equivalents Cash and Cash Equivalent Research and Development Arrangement, Contract to Perform for Others, Type [Axis] Cybersecurity Risk Management, Strategy, and Governance [Abstract] Common Stock, Shares, Issued, Total Common stock, shares issued Common Stock, Shares, Issued Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag] Cybersecurity Risk Board of Directors Oversight [Text Block] Description of additional lease space Lessee, Operating Lease, Description Statement [Table] Statement [Table] Tax positions related to the current year Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions Operating lease liabilities arising from obtaining right-of-use assets Increase in operating lease right-of-use assets and lease liabilities related to new lease Right-of-Use Asset Obtained in Exchange for Operating Lease Liability Prepaid expenses Increase (Decrease) in Prepaid Expense Share-Based Payment Arrangement, Disclosure [Abstract] Weighted average grant date fair value per granted option Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Statement [Line Items] Statement [Line Items] Proceeds from issuance of ordinary shares pursuant to the GSK Collaboration Agreement Proceeds from issuance of ordinary shares pursuant to the GSK Collaboration Agreement Proceeds from issuance of ordinary shares pursuant to the GSK Collaboration Agreement. Revenue Recognition Revenue from Contract with Customer [Policy Text Block] Entity Filer Category Entity Filer Category Liabilities and Equity Total liabilities, Series A preferred shares and shareholders' equity Research and development tax credit carryforward expiration year Research And Development Tax Credit Carryforward Expiration Year Research and development tax credit carryforward expiration year. Payables and Accruals [Abstract] Options exercisable, Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price Long-Lived Tangible Asset Long-Lived Tangible Asset [Axis] Increase in operating right-of-use assets. Increase In Operating Right Of Use Assets Increase in operating right-of-use assets Increase in valuation allowance Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount HD programs. HD Program [Member] Cybersecurity Risk Third Party Oversight and Identification Processes [Flag] Deferred Tax Assets, Valuation Allowance, Total Valuation allowance Balance at beginning of year Balance at end of year Deferred Tax Assets, Valuation Allowance Singapore statutory income tax rate, Percent Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent Share price Purchase price per share Shares Issued, Price Per Share Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount, Total Nontaxable or nondeductible items, Amount Cybersecurity Risk Management Third Party Engaged [Flag] Documents Incorporated by Reference Documents Incorporated by Reference [Text Block] Effective income tax rate, Percent Effective Income Tax Rate Reconciliation, Percent Options to Purchase Ordinary Shares [Member] Income Tax Authority Income Tax Jurisdiction [Axis] Net operating loss carryforwards available to offset future income tax liabilities indefinitely Deferred Tax Assets, Operating Loss Carryforwards, Not Subject to Expiration Geographical Geographical [Domain] Restricted Cash Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block] Long-term assets: Assets, Noncurrent [Abstract] Income Taxes [Table] Income Taxes [Table] Income Taxes [Table] Accrued expenses and other current liabilities Accrued Expenses And Other Current Liabilities Accrued expenses and other current liabilities. Significant Accounting Policies Significant Accounting Policies [Text Block] Property Plant And Equipment [Line Items] Property, Plant and Equipment [Line Items] Operating lease liabilities Deferred Tax Assets Tax Deferred Expense Operating Lease Liabilities Deferred tax assets tax deferred expense operating lease liabilities. INHBE program. INHBE Program [Member] Granted, Number of Shares Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Equity grants made to consultants GSK Collaboration Program [Member] GSK collaboration program. GSK Collaboration Programs [Member] Collaboration agreement commencement date Collaboration Agreement Commencement Date Collaboration agreement commencement date. Cybersecurity Risk Management, Strategy, and Governance [Table] Summary of Basic and Diluted Net Loss Per Ordinary Share Outstanding Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Earnings Per Share, Basic, Total Earnings Per Share, Basic Net loss per share, basic Net loss per share attributable to ordinary shareholders - basic Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Total Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Foreign currency translation gain (loss) Outstanding, Number of Shares, Beginning Balance Outstanding, Number of Shares, Ending Balance Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Total current liabilities Liabilities, Current Accounts receivable Increase (Decrease) in Accounts Receivable Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract] Adjustments to reconcile net loss to net cash provided by (used in) operating activities: Schedule Of Effective Income Tax Rate Reconciliation [Table] Schedule Of Effective Income Tax Rate Reconciliation [Table] Schedule Of Effective Income Tax Rate Reconciliation [Table] Federal [Member] Domestic Tax Jurisdiction [Member] Tax positions related to prior years Unrecognized Tax Benefits Increases Decreases Resulting From Prior Period Tax Positions Unrecognized tax benefits increases (decreases) resulting from prior period tax positions. SCA3 Category 1 Program [Member] SCA3 Category 1 program. Class Of Warrant Or Right Issued Class of warrant or right issued. Pre-funded warrant sold Equity, Attributable to Parent [Abstract] Shareholders' equity: Entity Small Business Entity Small Business Retained Earnings (Accumulated Deficit), Ending Balance Retained Earnings (Accumulated Deficit), Beginning Balance Retained Earnings (Accumulated Deficit), Total Accumulated deficit Retained Earnings (Accumulated Deficit) Deferred Tax Assets, Net of Valuation Allowance [Abstract] Share-based compensation Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost Entity Well-known Seasoned Issuer Entity Well-known Seasoned Issuer Net operating loss carryforwards available to offset future income tax liabilities Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration Forfeited or cancelled, Number of Shares Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Purchase price per share Sale of Stock, Price Per Share Options excercised intrinsic value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value Share-Based Compensation Share-Based Payment Arrangement [Text Block] Payments to Acquire Short-Term Investments Purchase of short-term investments Purchase of short-term investments Organization, Consolidation and Presentation of Financial Statements [Abstract] Defined Contribution Plan [Table] Defined Contribution Plan [Table] Leases [Abstract] Contract with Customer, Liability, Total Collaboration and license agreement, deferred revenue Contract with Customer, Liability Amendment Flag Amendment Flag Product and Service Product and Service [Domain] Tax Credit Carry Forward Expiration Year U.S.Orphan drug credit carryforward expiration year Tax credit carry forward expiration year Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount Singapore statutory income tax rate, Amount Proceeds from Issuance of Ordinary Shares, Net of Certain Offering Costs Proceeds from issuance of ordinary shares, net of certain offering costs. Proceeds from the issuance of ordinary shares as a part of the September 2024 Offering, net of offering costs Class of Warrant or Right, Number of Securities Called by Warrants or Rights Purchase price of pre-funded warrants Segment Reporting Information, Operating Income (Loss) [Abstract] Segment Reporting Information, Operating Expenses [Abstract] Net Loss per Share Earnings Per Share, Policy [Policy Text Block] Liabilities, Series A preferred shares and shareholders’ equity Liabilities and Equity [Abstract] Entity Address, Postal Zip Code Entity Address, Postal Zip Code Net cash used in operating activities Cash Provided by (Used in) Operating Activity, Including Discontinued Operation Ordinary Shares [Member] Common Stock [Member] Cybersecurity Risk Role of Management [Text Block] Tax credit carryforward Tax Credit Carryforward, Amount Discretionary contributions to defined contribution pension plan Defined Contribution Plan, Employer Discretionary Contribution Amount Shin Nippon Biomedical Laboratories Ltd [Member] Shin Nippon Biomedical Laboratories Ltd [Member] Shin Nippon Biomedical Laboratories Ltd. Granted, Weighted Average Exercise Price Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Lessee, Operating Lease, Liability, to be Paid, Year Three 2028 Net of accumulated depreciation Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Ending Balance Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Beginning Balance Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Total Less accumulated depreciation Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Voting rights, votes per share Common Stock Votes Per Share Common stock vote per share. Non Rule 10b 51 Arr Modified Flag Non-Rule 10b5-1 Arrangement Modified. Non-Rule 10b5-1 Arrangement Modified Research and Development Arrangement, Contract to Perform for Others, Type [Domain] Entity Address, Address Line One Entity Address, Address Line One Deferred Tax Liabilities, Gross, Total Total deferred tax liabilities Deferred Tax Liabilities, Gross Summary of Fair Value of Share Options Granted / Verdine Scientific Advisory Grant Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Fair Value Hierarchy and NAV [Axis] Earnings Per Share [Abstract] Income Taxes Income Tax, Policy [Policy Text Block] Temporary equity, Beginning balance Temporary equity, Ending balance Temporary Equity, Carrying Amount, Attributable to Parent Series A preferred shares, no par value; 3,901,348 shares issued and outstanding at December 31, 2025 and 2024 Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag] Foreign Currency Translation Foreign Currency Transactions and Translations Policy [Policy Text Block] Scientific Advisor [Member] Scientific Advisor [Member] Scientific Advisor [Member] Chandra Vargeese [Member] Chandra Vargeese. Investment Type [Axis] Investment Type Operating lease right-of-use assets Operating Lease, Right-of-Use Asset Total deferred tax assets Deferred Tax Assets, Gross Percentage of ownership interest at election of ordinary shares outstanding, minimum Percentage of ownership interest at election of ordinary shares outstanding, minimum. Operating loss carryforwards expiration year Operating Loss Carryforwards Expiration Year Operating loss carryforwards expiration year. Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block] Document Type Document Type Effect of foreign currency translation Deferred Tax Assets Valuation Foreign Currency Translation Deferred tax assets valuation foreign currency translation. Collaborative Arrangement and Arrangement Other than Collaborative Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Collaborative Arrangement and Arrangement Other than Collaborative Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Entity Central Index Key Entity Central Index Key Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block] Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation Net increase in cash, cash equivalents and restricted cash Subsequent Event Type [Domain] Offering costs in accounts payable at period end Offering costs in accounts payable Offering costs in accounts payable Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Anti-dilutive shares excluded from computation of diluted earnings Proceeds from Issuance of Warrants Proceeds from issuance pre-funded warrants, net of offering costs Outstanding, Weighted Average Remaining Contractual Term Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Expected volatility, maximum Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum Lexington, Massachusetts [Member] Lexington Massachusetts [Member] Lexington Massachusetts. Lexington Facility [Member] Defined Contribution Plan Disclosure [Line Items] Defined Contribution Plan Disclosure [Line Items] Foreign Tax Jurisdiction, Other [Member] ESPP [Member] Employee Share Purchase Plan [Member] Employee share purchase plan. Document Financial Statement Error Correction [Flag] Exercised, Number of Shares Option exercises, shares Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Supplemental Cash Flow Elements [Abstract] Supplemental disclosure of cash flow information: Number of research programs, counterparty nomination Counterparty Nominations Number Of Research Programs Counterparty nominations number of research programs. Accrued Liabilities, Current, Total Accrued expenses related to CROs and CMOs Accrued Liabilities, Current Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Current Fiscal Year End Date Current Fiscal Year End Date Restricted Cash and Cash Equivalents, Noncurrent, Total Restricted cash Restricted cash Restricted Cash and Cash Equivalent, Noncurrent RSUs outstanding Outstanding, Number of Shares, Beginning Balance Outstanding, Number of Shares, Ending Balance Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Income Taxes [Line Items] Income Taxes [Line Items] Income Taxes [Line Items] Comprehensive loss Comprehensive Income (Loss), Net of Tax, Attributable to Parent Research and Development Expenses Research and Development Expense, Policy [Policy Text Block] Ordinary shares reserved for issuance Common Stock, Capital Shares Reserved for Future Issuance Geographical Geographical [Axis] Consultant [Member] Consultant. Revenue recognized Contract with Customer, Liability, Revenue Recognized Percentage of global costs and potential profits sharing ratio Percentage Of Global Costs And Potential Profits Sharing Ratio Percentage of global costs and potential profits sharing ratio. Category Two Programs [Member] Category Two Programs [Member] Category two programs. Summary of Share-based Compensation Expense Classified in Consolidated Statements of Operations and Comprehensive Loss Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Option exercises Stock Issued During Period, Value, Stock Options Exercised Accrued Expenses and Other Current Liabilities Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block] Components of Deferred Tax Assets and Liabilities Schedule of Deferred Tax Assets and Liabilities [Table Text Block] Research, License and Option Agreement [Member] Research License And Option Agreement [Member] Research, license and option agreement. Collaboration Agreements Collaborative Arrangement Disclosure [Text Block] Other comprehensive loss: Other Comprehensive Income (Loss), Net of Tax [Abstract] Subsequent Event [Member] Subsequent Event [Member] Term deposits purchased and reached maturity current. Term Deposits Purchased And Reached Maturity Current Term deposits purchased and reached maturity Collaboration agreement, committed cash Collaboration Agreement Committed Cash Collaboration agreement committed cash. Property, Plant and Equipment [Abstract] Other Assets, Noncurrent Other assets Antidilutive Securities Antidilutive Securities [Axis] Going Concern Going Concern Policy [Text Block] Going concern. Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage Vesting percentage Fair value of RSUs vested Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value Discovery Research Collaboration [Member] Discovery research collaboration. December 2025 Offering [Member] December Two Thousand Twenty Five Offering [Member] December 2025 offering. State [Member] State and Local Jurisdiction [Member] Performance Based Restricted Stock Units [Member] Performance based restricted stock units. Performance Based RSUs [Member] Related Party Transaction Related Party Transaction [Axis] Increase in valuation allowance Deferred Tax Assets Valuation Allowance Increase Deferred tax assets valuation allowance increase. Accumulated Other Comprehensive Income (Loss) [Member] AOCI Attributable to Parent [Member] Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology [Abstract] Collaboration And License Agreement [Member] Collaboration And License Agreement [Member] Collaboration and license agreement. Lease option to extend description Lessee, Operating Lease, Option to Extend Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract] Deferred benefit for income taxes: Minimum [Member] Minimum [Member] Granted, Average Grant Date Fair Value Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Current assets: Assets, Current [Abstract] Operating Loss Carry forward expiration year Operating Loss Carry Forward Expiration Year Operating Loss Carry forward expiration year. Collaboration and license agreement month and year Collaboration And License Agreement Month And Year Collaboration and license agreement month and year. Segment Reporting [Abstract] Verdine Scientific Advisory Grant [Member] Verdine Scientific Advisory Grant [Member] Verdine scientific advisory grant. Current liabilities: Liabilities, Current [Abstract] Related Party Transactions [Abstract] Beginning balance, shares Ending balance, shares Shares, Outstanding Operating Loss Carryforwards, Total Net operating loss carryforwards Operating Loss Carryforwards Accounts receivable Accounts Receivable, after Allowance for Credit Loss, Current, Total Accounts Receivable, after Allowance for Credit Loss, Current Lease renewal term Lessee, Operating Lease, Renewal Term Proceeds from the ESPP Proceeds from Stock Plans Investment tax credit carryforward expiration year Investment Tax Credit Carryforward Expiration Year Investment tax credit carryforward expiration year. Leases Lessee, Leases [Policy Text Block] Outstanding, Average Grant Date Fair Value, Beginning Balance Outstanding, Average Grant Date Fair Value, Ending Balance Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Collaboration-budgeted research and preclinical expenses Collaboration Budgeted Research And Preclinical Expenses collaboration-budgeted research and preclinical expenses. General and Administrative Expenses [Member] General and Administrative Expense [Member] Revenue, practical expedient, incremental costs of obtaining contract Revenue, Practical Expedient, Incremental Cost of Obtaining Contract [true false] Operating Lease, Liability, Total Total operating lease liabilities Operating lease liability Operating Lease, Liability Auditor Firm ID Auditor Firm ID Fund receivable for research and preclinical activities Fund Receivable For Research And Preclinical Activities Fund receivable for research and preclinical activities. Common stock, par value Common Stock, No Par Value Incremental borrowing rate. Incremental borrowing rate Ordinary share purchase price at equal to fair market value percentage Share Purchase Price At Equal To Fair Market Value Percentage Share purchase price at equal to fair market value percentage. Gross proceeds from sale of ordinary shares Gross Proceeds From Issuance Of Common Stock Gross proceeds from issuance of common stock. Accumulated depreciation Deferred Tax Assets Accumulated Depreciation Deferred tax assets accumulated depreciation. Effective Income Tax Rate Reconciliation, Changes in unrecognized tax benefits, Amount Effective Income Tax Rate Reconciliation, Changes in unrecognized tax benefits, Amount. Changes in unrecognized tax benefits, Amount Changes in valuation allowances, Percent Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent Long-term liabilities: Liabilities, Noncurrent [Abstract] Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations, Total Effect of foreign exchange rates on cash Effect of Exchange Rate on Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Including Discontinued Operation Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Total Net loss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Up-front consideration received Up Front Consideration Received Up-front consideration received. Cybersecurity Risk Management Positions or Committees Responsible [Text Block] Weighted Average Number of Shares Outstanding, Basic, Total Weighted Average Number of Shares Outstanding, Basic Weighted-average ordinary shares outstanding, basic Weighted-average ordinary shares used in computing net loss per share attributable to ordinary shareholders - basic 2021 Plan [Member] Two Thousand Twenty One Equity Incentive Plan [Member] 2021 equity incentive plan. Effective Income Tax Rate Reconciliation Return to provision Effective income tax rate reconciliation return to provision. Return to provision Paul B. Bolno [Member] Paul B. Bolno. Options exercisable, Aggregate Intrinsic Value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value Segment Reporting, Expense Information Used by CODM, Description Effective Income Tax Rate Reconciliation, Changes in unrecognized tax benefits, Percent Effective Income Tax Rate Reconciliation, Changes in unrecognized tax benefits, Percent. Changes in unrecognized tax benefits, Percent Other, Amount Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount Reconciliation of Statutory Income Tax Rate Schedule of Effective Income Tax Rate Reconciliation [Table Text Block] Operating lease right-of-use assets Deferred Tax Liabilities, Leasing Arrangements September 2024 Offering [Member] September Two Thousand Twenty Four Offering [Member] September two thousand twenty four offering. Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Schedule Of Operating Leased Assets [Table] Schedule of Operating Leased Assets [Table] Long-Lived Tangible Asset Long-Lived Tangible Asset [Domain] Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block] At-The-Market Equity Program [Member]​ At The Market Equity Program [Member] At-the-market equity program. Deferred tax assets: Deferred Tax Assets, Net [Abstract] Subsequent Events [Text Block] Subsequent Events Effective Income Tax Rate Reconciliation, Tax Credit, Percent Effective Income Tax Rate Reconciliation, Tax Credit, Percent, Total Federal and state tax credits Federal and state tax credits Related Parties Related Party Transactions Disclosure [Text Block] Cash, Ending Balance Cash, Beginning Balance Cash held by subsidiaries Cash Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount Change in valuation allowances, Amount Beginning balance Ending balance Equity, Attributable to Parent Total shareholders' equity Option to extend the lease Lessee, Operating Lease, Existence of Option to Extend [true false] Statement of Stockholders' Equity [Abstract] Series A Preferred Shares [Member] Series A Preferred Stock [Member] Use of Estimates Use of Estimates, Policy [Policy Text Block] Other information Other Information Pertaining To Operating Leases [Abstract] Other information pertaining to operating leases. Collaborative Arrangement Initiation Payment Collaborative arrangement initiation payment. Aggregate initiation payment Leasehold Improvements [Member] Leasehold Improvements [Member] Entity Address, Address Line Two Entity Address, Address Line Two License Agreements and Patent Costs Revenue From Contract With Customer License Agreements And Patent Costs Policy [Text Block] Revenue from contract with customer license agreements and patent costs. United States [Member] UNITED STATES Warrants and Rights Note Disclosure [Abstract] Nondeductible executive compensation, Amount Effective Income Tax Rate Reconciliation, Nondeductible Expense, Executive Compensation, Amount Effective income tax rate reconciliation, Nondeductible expense, Executive compensation, Amount. Summary of Accrued Expenses and Other Current Liabilities Schedule of Accrued Liabilities [Table Text Block] Other current assets Other Assets, Current Total accrued expenses and other current liabilities Accrued expenses and other current liabilities Accrued Liabilities and Other Liabilities Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block] Summary of Activity in Gross Unrecognized Tax Benefits Excluding Interest and Penalties Segment Reporting, CODM, Individual Title and Position or Group Name [Extensible Enumeration] Deferred tax assets valuation allowance decrease. Deferred Tax Assets Valuation Allowance Decrease Decrease in valuation allowance Plan Name Plan Name [Domain] Other assets Increase (Decrease) in Other Operating Assets, Total Increase (Decrease) in Other Operating Assets Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis] Effective income tax rate reconciliation change in reserve for uncertain tax positions. Effective Income Tax Rate Reconciliation Change In Reserve For Uncertain Tax Positions Changes in reserves for uncertain tax positions Non Employee [Member] Non Employee [Member] Non employee. AATD Program [Member] AATD program. Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block] Cybersecurity Risk Management Expertise of Management Responsible [Text Block] Class of Warrant or Right, Outstanding Pre-funded warrant outstanding Upfront payment under collaboration agreement Collaboration Agreement Upfront Payment Collaboration agreement upfront payment. Kyle Moran. Kyle Moran [Member] Operating Lease Liabilities, Payments Due [Abstract] Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract] Related Party Related and Nonrelated Parties [Axis] Class of Warrant or Right [Table] Pfizer Inc. [Member] Pfizer Inc [Member] Pfizer Inc. Property and Equipment Property, Plant and Equipment, Policy [Policy Text Block] Entity Address, City or Town Entity Address, City or Town Number of Reportable Segments Security Exchange Name Security Exchange Name Property, Plant and Equipment, Gross, Ending Balance Property, Plant and Equipment, Gross, Beginning Balance Property, Plant and Equipment, Gross, Total Property and equipment gross Property, Plant and Equipment, Gross Current Income Tax Expense (Benefit), Continuing Operations [Abstract] Current benefit (provision) for income taxes: Rest Of World [Member] Rest Of World [Member] Rest of World. Counterparty Name Counterparty Name [Axis] Loss before income taxes Loss before income taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Research term, description Research Term Description Research term description. Impairment of Long-Lived Assets Impairment or Disposal of Long-Lived Assets, Including Intangible Assets, Policy [Policy Text Block] Antidilutive Securities, Name Antidilutive Securities, Name [Domain] Foreign rate differential, Percent Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent Percentage of ownership interest in ordinary shares outstanding. Percentage of ownership interest in ordinary shares outstanding Minimum percentage of combined voting power of securities outstanding immediate effect of exercise June 2022 Offering. June 2022 Offering [Member] Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table] Statistical Measurement Statistical Measurement [Domain] Lessee Operating Lease Liability To Be Paid Year Four And Thereafter Lessee operating lease liability to be paid year four and thereafter. 2029 and thereafter Class of Warrant or Right, Exercise Price of Warrants or Rights Pre-funded warrant exercise price per share Warrant Exercise Price Per Share Total current assets Assets, Current Share-based compensation expense Share-Based Payment Arrangement, Expense Summary Of Allocation of The Total Transaction Price Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table Text Block] Period End Date Document Period End Date Document Period End Date Title of Individual Title and Position [Axis] Fair Value Hierarchy and NAV [Domain] ICFR Auditor Attestation Flag ICFR Auditor Attestation Flag Options exercisable, Number of Shares Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number Gain (Loss) on Disposition of Property Plant Equipment, Total Gain (Loss) on Disposition of Property Plant Equipment Net loss on disposal of property and equipment Loss on disposal of property and equipment Equipment, Furniture and Software [Member] Equipment Furniture And Software [Member] Equipment, Furniture and Software. Statement of Financial Position [Abstract] RSUs [Member] Restricted Stock Units (RSUs) [Member] Effective Income Tax Rate Reconciliation, Tax Credit, Orphan drug credit, Amount Effective income tax rate reconciliation, Tax credit, Orphan drug credit, Amount. Orphan drug credit, Amount Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table] Antidilutive Security, Excluded EPS Calculation [Table] Class of Stock Class of Stock [Axis] Employee Benefit Plans Compensation and Employee Benefit Plans [Text Block] Current Income Tax Expense (Benefit), Total Current Income Tax Expense (Benefit) Total current benefit for income taxes Cybersecurity Risk Management, Strategy, and Governance [Line Items] Cambridge MA [Member] Cambridge M A [Member] Cambridge MA. Tax rate change Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent Total liabilities Liabilities Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount Foreign rate difference, Amount Lessee, Operating Lease, Liability, to be Paid, Year Two 2027 Weighted Average Number of Shares Outstanding, Diluted, Total Weighted Average Number of Shares Outstanding, Diluted Weighted-average ordinary shares outstanding, diluted Weighted-average ordinary shares used in computing net loss per share attributable to ordinary shareholders - diluted Collaboration And Share Purchase Agreements [Abstract] Collaboration and Share Purchase Agreements [Abstract] Entity File Number Entity File Number 401(k) Plan [Member] Four Zero One K Plan [Member] Four Zero One K Plan [Member] Effective Income Tax Rate Reconciliation, Other Reconciling Items, Percent Other, Percent Gross proceeds related to exercise of underwriters' option Gross proceeds related to exercise of underwriters' option. Proceeds from Sale, Maturity and Collection of Short-Term Investments, Total Proceeds from Sale, Maturity and Collection of Short-Term Investments Proceeds from the maturity of short-term investments Cover Cover [Abstract] Expected volatility, minimum Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum Transaction Price Unsatisfied Transaction Price Unsatisfied To Performance Obligation Transaction price unsatisfied to performance obligation. Forfeited, Number of Shares Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period Milestone payment Collaborative Arrangements Milestone Payment Collaborative arrangements milestone payment. Investment Type Investments [Domain] Summary of Valuation Allowance Summary of Valuation Allowance [Table Text Block] Singapore [Member] SINGAPORE Increase in shares of common stock authorized for issuance Ordinary shares authorized for issuance Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized Number of operating segment Number of Operating Segments Sale of Stock Sale of Stock [Domain] Professional and Contract Services Expense, Total Consulting service expenses Professional and Contract Services Expense Effective Income Tax Rate Reconciliation Permanent Differences Effective Income Tax Rate Reconciliation Permanent Differences Permanent differences Segment Reporting Disclosure [Text Block] Segment Information General and Administrative Expense, Total General and administrative General and Administrative Expense General and administrative expenses Operating Leased Assets [Line Items] Operating Leased Assets [Line Items] Other Deferred Tax Assets, Other Adjustments to Additional Paid in Capital, Warrant Issued Issuance of pre-funded warrants, net of offering costs Property and equipment, estimated useful lives Property, Plant and Equipment, Useful Life Recently Issued Accounting Pronouncements New Accounting Pronouncements, Policy [Policy Text Block] Schedule of Future Minimum Rental Payments for Operating Leases Under Topic 842 Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Minimum percentage of combined voting power of securities outstanding immediate effect of exercise. Minimum percentage of combined voting power of securities outstanding immediate effect of exercise Collaboration and license agreement, deferred revenue current Current portion of deferred revenue Contract with Customer, Liability, Current Vesting period Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period DMD programs. DMD Program [Member] DMD Program [Member] AATD Collaboration [Member] AATD Collaboration. Risk-free interest rate, minimum Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum Income Tax Expense (Benefit), Effective Income Tax Rate Reconciliation, Amount [Abstract] Depreciation, Total Depreciation expense Depreciation of property and equipment Depreciation Investment, Type [Extensible Enumeration] Accumulated amortization Deferred Tax Assets Tax Deferred Expense Accumulated Amortization Deferred tax assets tax deferred expense accumulated amortization. Unrecognized stock-based compensation expense Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount Lease agreement term Lessee, Operating Lease, Term of Contract Common Stock, Shares, Outstanding, Ending Balance Common Stock, Shares, Outstanding, Beginning Balance Common stock, shares outstanding Common Stock, Shares, Outstanding Current portion of operating lease liability Operating Lease, Liability, Current Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Revenue, Remaining Performance Obligation, Amount Transaction Price Cybersecurity Risk Management Processes Integrated [Flag] Document Transition Report Document Transition Report Net deferred tax assets (liabilities) Deferred Tax Assets, Net 2014 Plan [Member] Two Thousand Fourteen Equity Incentive Plan [Member] Two thousand fourteen equity incentive plan. Total operating expenses Operating Expenses Research and development Research and Development Expense Total research and development expenses Leases Lessee, Operating Leases [Text Block] Deferred Components of Benefit (Provision), Net for Income Taxes Schedule of Components of Income Tax Expense (Benefit) [Table Text Block] Statement of Cash Flows [Abstract] Collaboration Agreement in Premium Collaboration agreement in premium. Collaboration Agreement in Premium Equity investment aggregate purchase price Issuance of ordinary shares Stock Issued During Period, Value, New Issues Summary of Share Option Activity Share-Based Payment Arrangement, Option, Activity [Table Text Block] Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Percent Stock compensation, Percent Share Capital Equity [Text Block] Category 1 Programs and Category 2 Programs [Member] Category One Programs And Category Two Programs [Member] Category one programs and category two programs. Net Loss Per Ordinary Share Earnings Per Share [Text Block] Operating lease liabilities Increase Decrease In Operating Lease Liabilities Increase (decrease) in Operating lease liabilities. Unrecognized tax benefit that could affect annual effective tax rate if recognized Unrecognized Tax Benefits that Would Impact Effective Tax Rate Summary of RSU Activity Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block] Other Deferred Tax Liabilities, Other Cybersecurity Risk Management Processes Integrated [Text Block] Net loss Outstanding, Aggregate Intrinsic Value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value Operating lease cost Operating Lease, Cost Expected dividend yield Expected dividend rate Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate Option to reach maximum targets for preclinical programs Option To Reach Maximum Targets For Preclinical Programs Option to reach maximum targets for preclinical programs. Operating cash flows used for operating leases Operating Lease, Payments Assets Assets [Abstract] Fixed Assets in Progress [Member] Construction in Progress [Member] Document Fiscal Year Focus Document Fiscal Year Focus Revenue recognition performance obligation, expected time satisfaction period Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period Cash flows from investing activities Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract] Retirement Benefits [Abstract] Accounts Payable, Current, Total Accounts payable Accounts Payable, Current Aggregate fair value of options vested Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested in Period, Fair Value Research Term [Member] Research Terms [Member] Research term. Components of Loss before Income Taxes Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block] Research and Development Expenses [Member] Research and Development Expense [Member] Maximum targets for preclinical programs Maximum Targets For Preclinical Programs Maximum targets for preclinical programs. Renewal options Lessee Leasing Arrangements Operating Leases Renewal Term Description Lessee leasing arrangements operating leases renewal term description. Time-based RSUs [Member] Time Based Restricted Stock Units [Member] Time-based restricted stock units. U.S. Tax Guidance relating to Capitalization of Research and Development Expenditures [Member] U.S. tax guidance relating to capitalization of research and development expenditures member. Tax Credit Carryforward, Expiration Date Tax credit carryforward expiration year Unrecognized Tax Benefits [Roll Forward] Proceeds from the exercise of share options Proceeds from Stock Options Exercised Commitments and Contingencies Disclosure [Abstract] Service Period of October 1, 2022 Through December 31, 2024 [Member] Service period of october12022 through december312024 member. Service Period Of October12022 Through December312024 Member [member] Lessee, Operating Lease, Liability, to be Paid, Year One 2026 December 2023 Offering [Member] December 2023 Offering [Member] December 2023 offering. Net Income (Loss) Available to Common Stockholders, Basic, Total Net loss attributable to ordinary shareholders Net Income (Loss) Available to Common Stockholders, Basic Share-Based Payment Arrangement [Abstract] Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount, Total Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount Share-based compensation expense not yet recognized Sale of Stock Sale of Stock [Axis] Payments related to contract research services. Payments Related to Contract Research Services Payments related to contract research services. Investment Investment Tax Credit Carryforwards [Member] Investment tax credit carryforwards. Net cash used in investing activities Cash Provided by (Used in) Investing Activity, Including Discontinued Operation GSK equity investment. G S K Equity Investment [Member] GSK Equity Investment [Member] Title of 12(b) Security Title of 12(b) Security Schedule of Segment Reporting Information, by Segment [Table] Deferred tax liabilities: Deferred Tax Liabilities, Net [Abstract] Stock compensation, Amount Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Amount Deferred tax adjustments Effective Income Tax Rate Reconciliation Deferred Tax Adjustments Effective income tax rate reconciliation deferred tax adjustments. Forfeited or cancelled, Weighted Average Exercise Price Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Forfeited, Average Grant Date Fair Value Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Deferred tax assets capitalized research and development. Deferred Tax Assets Capitalized Research And Development Capitalized research and development Capitalized research and development deferred tax assets GSK Collaboration Agreement [Member] GSK collaboration agreement. GSK Collaboration Agreement [Member] Maximum Termination Notice Period Maximum termination notice period. Collaboration agreement termination period Related and Nonrelated Parties [Domain] Income Taxes Income Tax Disclosure [Text Block] Schedule Of Collaborative Arrangements And Noncollaborative Arrangement Transactions [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Table] Series A preferred stock, shares issued Temporary Equity, Shares Issued Class of Warrant or Right [Line Items] C9-ALS/FTD Program [Member] C9-ALS/FTD Program Member C9-ALS/FTD program. Effective Income Tax Rate Reconciliation, Orphan Drug, Research, Percent Effective income tax rate reconciliation, Orphan drug, Research, Percent. Orphan drug credit, Percent Consulting agreement termination notice period Agreement Termination Notice Period Agreement termination notice period. Warrant or Right, Reason for Issuance, Description Warrant or Right, Original issuance date, description Other Liabilities, Noncurrent, Total Other liabilities Other Liabilities, Noncurrent Consolidated Entities Consolidated Entities [Axis] Changes in operating assets and liabilities: Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract] Schedule of Property and Equipment, Net Property, Plant and Equipment [Table Text Block] Outstanding, Weighted Average Exercise Price, Beginning Balance Outstanding, Weighted Average Exercise Price, Ending Balance Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Proceeds from issuance of ordinary shares pursuant to at-the-market equity program net. Proceeds From Issuance Of Ordinary Shares Pursuant To At-the-market Equity Program Net Proceeds from issuance of ordinary shares pursuant to the at-the-market equity program, net Income Tax Disclosure [Abstract] Acheivement of milestone included in current portion receivable Acheivement Of Milestone Included In Current Portion Receivable Acheivement of milestone included in current portion receivable Gross unrecognized tax benefit Unrecognized tax benefit at the beginning of the year Unrecognized tax benefit at the end of the year Unrecognized Tax Benefits Additional Paid-In-Capital [Member] Additional Paid-in Capital [Member] Accrued expenses and other current liabilities Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities UK [Member] UNITED KINGDOM Income Statement Location Statement of Income Location, Balance [Axis] Research and development Research And Development Tax Credit Carryforward [Member] Research and development tax credit carryforward. Trading Symbol Trading Symbol Property and Equipment, Net Property, Plant and Equipment Disclosure [Text Block] Tax years open to examination Open Tax Year Schedule Of Related Party Transactions By Related Party [Table] Related Party Transaction [Table] Risk-free interest rate, maximum Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent Nontaxable or nondeductible items, Percent Nontaxable or nondeductible items, Percent Subsequent Event Type [Axis] Employee-related Liabilities, Current, Total Accrued compensation Employee-related Liabilities, Current Cash flows from financing activities Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract] Expected term (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term Total lease payments Lessee, Operating Lease, Liability, to be Paid Preferred stock liquidation preference, per share Preferred Stock, Liquidation Preference Per Share Less: imputed interest Lessee, Operating Lease, Liability, Undiscounted Excess Amount Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent Research and development tax credits Research and development tax credits, Percent Orphan drug credits. Orphan Drug Credits Orphan Drug Credits [Member] Schedule of Estimated Useful Life of Assets Property Plant And Equipment Estimated Useful Lives Table [Text Block] Property Plant And Equipment Estimated Useful Lives Table [Text Block] Equity Components Equity Components [Axis] Collaboration and Share Purchase Agreements [Member] Collaboration And Share Purchase Agreements [Member] Collaboration and share purchase agreements. Total other income, net Nonoperating Income (Expense) Percentage of Ownership Interest at Election of Ordinary Shares Outstanding Maximum Percentage of ownership interest at election of ordinary shares outstanding maximum. Percentage of ownership interest at election of ordinary shares outstanding maximum Equity Component Equity Component [Domain] Equity investment agreement official closure month and year Equity Investment Agreement Official Closure Date Month And Year Equity investment agreement official closure date month and year. Deferred revenue Deferred Tax Assets, Deferred Income Document Annual Report Document Annual Report Follow-On Underwritten Public Offering [Member] IPO [Member] Postemployment Benefits [Abstract] Share-based compensation Shares Issued, Value, Share-Based Payment Arrangement, before Forfeiture Issuance of ordinary shares under ESPP, shares Stock Issued During Period, Shares, Employee Stock Purchase Plans HD Target under Takeda Collaboration Agreement [Member] HD Target under Takeda Collaboration Agreement. HD Target under Takeda Collaboration Agreement [Member] Subsidiaries Outside of Singapore [Member] Subsidiaries [Member] Contractual life of options Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period Investment Income, Interest and Dividend, Total Dividend income and interest income, net Investment Income, Interest and Dividend September 2024 Offering [Member] September 2024 Offering. September 2024 Offering [Member] Ordinary share holder, voting right Common Stock, Voting Rights Maximum [Member] Maximum [Member] Cambridge, Massachusetts [Member] Cambridge Massachusetts [Member] Cambridge, Massachusetts. Statistical Measurement Statistical Measurement [Axis] Exercised, Weighted Average Exercise Price Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Collaboration and license agreement, deferred revenue noncurrent Deferred revenue, net of current portion Deferred revenue, net of current portion Prepaid Expense, Current, Total Prepaid expenses Prepaid Expense, Current Common Stock, Value, Issued, Ending Balance Common Stock, Value, Issued, Beginning Balance Common Stock, Value, Issued, Total Common Stock, Value, Issued Ordinary shares, no par value; 187,660,263 and 153,037,286 shares issued and outstanding at December 31, 2025 and 2024, respectively Principles of Consolidation Consolidation, Policy [Policy Text Block] Deferred Tax Assets, Operating Loss Carryforwards, Total Net operating loss carryovers Net operating loss carryforwards Deferred Tax Assets, Operating Loss Carryforwards Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block] Tax Credit Carryforward Tax Credit Carryforward [Axis] Collaboration and License Agreement Date Collaboration And License Agreement Date Collaboration and license agreement date. Entity Public Float Entity Public Float Preferred stock, shares authorized Preferred Stock, Shares Authorized Federal and State. Federal And State [Member] Federal and State [Member] Related Party Transaction [Line Items] Related Party Transaction [Line Items] Entity Registrant Name Entity Registrant Name Income tax examination, likelihood of settlement, percentage Income Taxes Examination Likelihood Of Realization On Settlement Percentage Income taxes examination likelihood of realization on settlement percentage. Entity Voluntary Filers Entity Voluntary Filers Other Nonoperating Income (Expense), Total Other Nonoperating Income (Expense) Other income, net Additional Paid in Capital, Ending Balance Additional Paid in Capital, Beginning Balance Additional Paid in Capital, Total Additional paid-in capital Additional Paid in Capital Subsequent Events [Abstract] Cybersecurity Risk Management Positions or Committees Responsible [Flag] Consolidated Entities Consolidated Entities [Domain] Income Tax Expense (Benefit) Income tax benefit (provision) Income tax benefit Effective income tax rate Total benefit for income taxes Proceeds from issuance of ordinary shares Net proceeds from sale of ordinary shares Proceeds from the issuance of ordinary shares as a part of the June 2022 Offering, net of offering costs Developmental Milestone related to HD Category One Program, Which Pertained to Completion of New, Non-Clinical Study of WVE-003 in Non-Human Primates or NHPs [Member] Developmental Milestone related to HD Category One Program, Which Pertained to Completion of New, Non-Clinical Study of WVE-003 in Non-Human Primates or NHPs [Member] Developmental milestone related to HD Category 1 Program, which pertained to completion of new, non-clinical study of WVE-003 in non-human primates or NHPs member. Share-based Compensation Arrangement By Share-based Payment Award [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Mr. Moran [Member] Mr. Moran. Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Concentration of Credit Risk Concentration Risk, Credit Risk, Policy [Policy Text Block] Unconstrained revenue Deferred Revenue, Revenue Recognized Accumulated other comprehensive loss Accumulated Other Comprehensive Income (Loss), Net of Tax, Total Accumulated Other Comprehensive Income (Loss), Net of Tax Revenue from termination of collaborative arrangement Revenue from Collaborative Arrangement, Excluding Revenue from Contract with Customer Payments to Acquire Property, Plant, and Equipment, Total Purchases of property and equipment Payments to Acquire Property, Plant, and Equipment Shares granted to employees Granted, Number of Shares Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Total assets Assets Schedule Of Property Plant And Equipment [Table] Property, Plant and Equipment [Table] Options exercisable, Weighted Average Remaining Contractual Term Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Income Statement [Abstract] Takeda [Member] Takeda Pharmaceutical Company Limited [Member] Takeda pharmaceutical company limited. Fair Value of Financial Instruments Fair Value of Financial Instruments, Policy [Policy Text Block] Tax positions related to prior years Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions Tax position releases Share-Based Compensation Share-Based Payment Arrangement [Policy Text Block] Preferred stock, par value Preferred Stock, No Par Value Deferred Income Tax Expense (Benefit), Total Deferred Income Tax Expense (Benefit) Total deferred benefit (provision) for income taxes Additional shares of common stock Sale of Stock, Number of Shares Issued in Transaction Shares issued under equity agreement Issuance of ordinary shares, shares Stock Issued During Period, Shares, New Issues Lease cost Lease, Cost [Abstract] Vested, Number of Shares Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period Earnings Per Share, Diluted, Total Earnings Per Share, Diluted Net loss per share, diluted Net loss per share attributable to ordinary shareholders - diluted Schedule of Segment Reporting Information, by Segment [Table Text Block] Schedule of Reconciliation to Consolidated Operating Expenses Effective Income Tax Rate Reconciliation, Percent [Abstract] Title of Individual Title and Position [Domain] Property, Plant, and Equipment, Useful Life, Term, Description [Extensible Enumeration] City Area Code City Area Code Christian Henry [Member] Christian Henry. Significant Accounting Policies [Line Items] Significant Accounting Policies [Line Items] Significant Accounting Policies [Line Items] Other Comprehensive Income (Loss), Net of Tax, Total Other Comprehensive Income (Loss), Net of Tax Other comprehensive loss Auditor Name Auditor Name Inland Revenue Authority of Singapore. Inland Revenue Authority of Singapore [Member] Inland Revenue Authority of Singapore (IRAS) [Member] Deferred Tax Assets, Tax Credit Carryforwards, Total Federal and state tax credits Deferred Tax Assets, Tax Credit Carryforwards Dr. Vargeese [Member] Dr. Vargeese. Counterparty Name Counterparty Name [Domain] Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount Research and development tax credits, Amount Variable lease cost Variable Lease, Cost Issuance of ordinary shares under the ESPP Stock Issued During Period, Value, Employee Stock Purchase Plan Collaborative Arrangement Initiation Payment Received Collaborative arrangement initiation payment received. Collaborative arrangement initiation payment received Weighted average remaining lease term Operating Lease, Weighted Average Remaining Lease Term Segment Reporting Information [Line Items] Total lease cost Lease, Cost Pre Funded Warrants. Pre Funded Warrants (Member) Pre Funded Warrants [Member] Cash and Cash Equivalents, Policy [Policy Text Block] Cash and Cash Equivalents Property, Plant and Equipment, Net, Ending Balance Property, Plant and Equipment, Net, Beginning Balance Property and equipment, net Property, Plant and Equipment, Net Property and equipment, net of accumulated depreciation of $49,522 and $46,329 as of December 31, 2025 and 2024 respectively Net proceeds from sale of ordinary shares after deducting commissions and offering expenses Proceeds From Issuance Of Common Stock Excluding Unpaid Offering Expenses Proceeds from issuance of common stock excluding unpaid offering expenses. Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations, Total Cash, cash equivalents and restricted cash Cash, cash equivalents and restricted cash, beginning of period Cash, cash equivalents and restricted cash, end of period Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Including Discontinued Operation Loss from operations Operating Income (Loss) Effective Income Tax Rate Reconciliation, Nondeductible Expense, Executive Compensation, Percent Effective Income Tax Rate Reconciliation, Nondeductible Expense, Executive Compensation, Percent. Nondeductible executive compensation, Percent Accumulated Deficit [Member] Retained Earnings [Member] Entity Address, Country Entity Address, Country Total long-term assets Assets, Noncurrent Percentage of combined voting power of securities outstanding at election of immediate effect of exercise minimum Percentage of combined voting power of securities outstanding at election of immediate effect of exercise minimum. Total long-term liabilities Liabilities, Noncurrent Category One Programs [Member] Category One Programs [Member] Category one programs. Weighted average discount rate Operating Lease, Weighted Average Discount Rate, Percent Percentage of combined voting power of securities outstanding at election of immediate effect of exercise maximum Percentage of combined voting power of securities outstanding at election of immediate effect of exercise maximum. Operating lease liability, net of current portion Operating Lease, Liability, Noncurrent Class of Stock [Line Items] Class of Stock [Line Items] Net cash provided by financing activities Cash Provided by (Used in) Financing Activity, Including Discontinued Operation Summary of Lease Costs Recognized and Other Information Pertaining to Operating Leases Lease, Cost [Table Text Block] Auditor Location Auditor Location Other income, net: Nonoperating Income (Expense) [Abstract] Collaborative agreement research term Collaborative Agreement Research Period Collaborative agreement research period. Description of Income tax benefit, likelihood of realized upon ultimate settlement Income Tax Examination, Likelihood of Unfavorable Settlement Anti-Dilutive Shares Excluded from Calculation of Diluted Net Loss Per Ordinary Share Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Income Tax Authority Income Tax Jurisdiction [Domain] Entity Interactive Data Current Entity Interactive Data Current Deferred revenue Increase (Decrease) in Contract with Customer, Liability SCA3 Program [Member] SCA3 Program [Member] SCA3 Program. Income Statement Location Statement of Income Location, Balance [Domain] Cash flows from operating activities Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract] Furniture and Equipment [Member] Furniture and Fixtures [Member] Other non-current liabilities Increase (Decrease) in Other Noncurrent Liabilities Vesting of RSUs, shares Stock Issued During Period Shares Restricted Stock Award Vested Stock issued during period shares restricted stock award vested. Amortization of right-of-use assets Amortization Of Right Of Use Assets Amortization of right-of-use assets. Stock Issued During Period, Shares, Issued for Services Non-qualified share option granted for service Stock issued during period, shares, issued for services Entity Tax Identification Number Entity Tax Identification Number The Company Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Collaborative Arrangement Transaction Statement Of Income Or Comprehensive Income Extensible Enumeration Not Disclosed Flag Collaborative arrangement transaction statement of income or comprehensive income extensible enumeration not disclosed flag. Local Phone Number Local Phone Number Related Party Transaction Related Party Transaction [Domain] Unrecognized stock-based compensation expense Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount Number Of Authorized Shares Not Disclosed Number of authorized shares not disclosed. Number of authorized shares not disclosed Denominator: Weighted Average Number of Shares Outstanding, Diluted [Abstract] Auditor Opinion [Text Block] Accounting Policies [Abstract] Research term under collaboration and license agreement Collaboration And License Agreement Research Term Collaboration and license agreement research term. Revenue from Contract with Customer, Excluding Assessed Tax, Total Collaboration revenue recognized Revenue Revenue from Contract with Customer, Excluding Assessed Tax Numerator: Net Income (Loss) Attributable to Parent [Abstract] Class of Stock Class of Stock [Domain] Other Research and Development Expenses, Including PNPLA3, Additional Preclinical Programs, PRISM [Member] Other research and development expenses, including PNPLA3, additional preclinical programs, PRISM [Member] Other research and development expenses, including PNPLA3, additional preclinical programs, PRISM. Ordinary shares available for future grant Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant Unrecognized stock-based compensation weighted average recognition period Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Schedule Of Stock By Class [Table] Stock, Class of Stock [Table] Entity Emerging Growth Company Entity Emerging Growth Company Significant Accounting Policies [Table] Significant Accounting Policies [Table] Significant Accounting Policies [Table] Tax Credit Carryforward, Name Tax Credit Carryforward, Name [Domain]